Kairbaan M Hodivala-Dilke

13PUBLICATIONS
70CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersEconomic models and forecastingMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 10, 2026
Advancing lung cancer therapy - leveraging cell biology to improve immunotherapy and anti-angiogenic strategies.

Jozafina Haj-Shomaly, Alejandro Castillo-Kauil, Carla Bloom

|Sep 15, 2025
Angiocrine and pericrine signaling: how endothelial cells and pericytes drive cancer progression and therapy resistance.

Alexander M Jordan, Rebecca J G Drake, Kairbaan M Hodivala-Dilke

|Jul 23, 2025
Angiocrine and Pericrine Signaling: How Endothelial Cells and Pericytes Drive Cancer Progression and Therapy Resistance.

Alexander M Jordan, Rebecca J G Drake, Kairbaan M Hodivala-Dilke

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Oct 24, 2023
Effects of senescence on the tumour microenvironment and response to therapy.

Louise E Reynolds, Seynab Maallin, Scott Haston

|Sep 06, 2023
Author Correction: Pericyte FAK negatively regulates Gas6/Axl signalling to suppress tumour angiogenesis and tumour growth.

Tanguy Lechertier, Louise E Reynolds, Hyojin Kim

Pageof 3